TAMIFLU

LOE Approaching

oseltamivir phosphate

NDAORALFOR SUSPENSIONPriority Review
Approved
Dec 2000
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Clinical Trials
22

Mechanism of Action

12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see ]. 12.3 Pharmacokinetics Absorption and Bioavailability Oseltamivir is absorbed from the gastrointestinal tract after oral administration of TAMIFLU (oseltamivir phosphate) and is extensively…

Clinical Trials (5)

NCT01556633Phase 1Completed

A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance

Started Mar 2012
16 enrolled
Healthy Volunteer
NCT00988325Phase 1Completed

A Pharmacokinetic/Pharmacodynamic (PK/PD) and Safety Evaluation of Oseltamivir [Tamiflu] in the Treatment of Infants 0 to <12 Months of Age With Confirmed Flu Infection

Started Jan 2011
65 enrolled
Influenza
NCT01053663Phase 1Terminated

A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza

Started Jan 2011
9 enrolled
Influenza
NCT01033734Phase 1Completed

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

Started Dec 2010
8 enrolled
Influenza
NCT01249833Phase 4Completed

Effect of Oseltamivir on Cognitive Function in Subjects With Influenza

Started Nov 2010
122 enrolled
Influenza